Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
want to be part of creating the future of human language technology, and do research that can enable the use of AI technology with low-resource languages, to help increase equality around the world? We
-
) starting on 1 October 2025, or as soon as possible thereafter. This position is part of the BIZPOWER (Business Power in the Politics of Wage Inequality and Climate Change) project, which investigates how
-
of Southern Denmark, Denmark. The successful candidates will study the physiology and ecology of microbial key players in global element cycles exposed to oxygen depletion. Aquatic oxygen-depleted environments
-
candidate with a strong background in ruminant nutrition and especially in forage evaluation and modelling rumen nutrient metabolism. The successful candidate is expected to take part in the initiatives
-
training. Responsibilities You will be part of the LightTrap project, funded by the Novo Nordisk Foundation, which aims to use AI to accelerate the discovery of new optical materials and nanostructures
-
appropriately structured for AI training. Responsibilities You will be part of the LightTrap project, funded by the Novo Nordisk Foundation, which aims to use AI to accelerate the discovery of new optical
-
. fellowships. You will receive training to develop grant writing and scientific communication skills. You will contribute to the daily lab management, attend project meetings and departmental seminars as part of
-
investigates protein disorder, dynamics and interactions. We are part of the Danish Center for Ultra-high field NMR spectroscopy and have access to facilities for SAXS, smFRET, etc. More information can be found
-
www.compute.dtu.dk . All engineering students must go through our department as part of their education at DTU. At the same time, we train many engineers who become specialists in our specific areas. Together
-
. The position is to be filled from August 1, 2025, or as soon as possible thereafter. The academic position The successful candidate will be part of our pharmacoepidemiological research group and work primarily